Validation of airway porcine epithelial cells as an alternative to human in vitro preclinical studies.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 09 2023
Historique:
received: 11 07 2023
accepted: 21 09 2023
medline: 4 10 2023
pubmed: 29 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Animal models are currently used in several fields of biomedical research as useful alternatives to human-based studies. However, the obtained results do not always effectively translate into clinical applications, due to interspecies anatomical and physiological differences. Detailed comparability studies are therefore required to verify whether the selected animal species could be a representative model for the disease or for cellular process under investigation. This has proven to be fundamental to obtaining reliable data from preclinical studies. Among the different species, swine is deemed an excellent animal model in many fields of biological research, and has been largely used in respiratory medicine, considering the high homology between human and swine airways. In the context of in vitro studies, the validation of porcine airway epithelial cells as an alternative to human epithelial cells is crucial. In this paper, porcine and human tracheal and bronchial epithelial cells are compared in terms of in vivo tissue architecture and in vitro cell behaviour under standard and airlifted conditions, analyzing the regenerative, proliferative and differentiative potentials of these cells. We report multiple analogies between the two species, validating the employment of porcine airway epithelial cells for most in vitro preclinical studies, although with some limitations due to species-related divergences.

Identifiants

pubmed: 37770485
doi: 10.1038/s41598-023-43284-7
pii: 10.1038/s41598-023-43284-7
pmc: PMC10539525
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16290

Informations de copyright

© 2023. Springer Nature Limited.

Références

Stem Cells Int. 2019 Feb 27;2019:7043890
pubmed: 30936924
Am J Pathol. 2010 Jul;177(1):362-76
pubmed: 20522644
Vet Immunol Immunopathol. 1994 Oct;43(1-3):185-91
pubmed: 7856051
Med Mycol. 2010 Dec;48(8):1049-55
pubmed: 20608777
J Biol Chem. 2010 Oct 29;285(44):34016-26
pubmed: 20724471
Laryngoscope Investig Otolaryngol. 2020 Jun 19;5(4):630-648
pubmed: 32864434
World J Urol. 2020 Sep;38(9):2115-2122
pubmed: 31289843
Am J Physiol Lung Cell Mol Physiol. 2008 Feb;294(2):L149-50
pubmed: 18024718
Dis Model Mech. 2018 Jan 22;11(1):
pubmed: 29419487
Vet Pathol. 2012 Mar;49(2):344-56
pubmed: 21441112
Front Bioeng Biotechnol. 2020 Aug 13;8:972
pubmed: 32903631
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12771-5
pubmed: 19625615
BMC Cell Biol. 2018 Jun 28;19(1):10
pubmed: 29954317
Curr Stem Cell Res Ther. 2016;11(8):643-651
pubmed: 26329484
J Thorac Cardiovasc Surg. 2010 Feb;139(2):437-43
pubmed: 19995663
J Cell Biol. 1999 May 17;145(4):769-82
pubmed: 10330405
Front Immunol. 2020 Jan 23;10:3060
pubmed: 32038617
Am J Transl Res. 2014 Jan 15;6(2):114-8
pubmed: 24489990
Am J Respir Cell Mol Biol. 2014 Oct;51(4):516-25
pubmed: 24754775
Vet Pathol. 2022 Jul;59(4):578-585
pubmed: 34794359
J Mol Med (Berl). 2010 Jul;88(7):653-64
pubmed: 20339830
Virology. 2019 Feb;528:152-163
pubmed: 30616205
Eur Arch Otorhinolaryngol. 2008 Sep;265(9):1075-81
pubmed: 18458926
Sci Immunol. 2019 Nov 1;4(41):
pubmed: 31676497
Proc Natl Acad Sci U S A. 1987 Apr;84(8):2302-6
pubmed: 2436229
Am J Physiol Lung Cell Mol Physiol. 2008 Aug;295(2):L240-63
pubmed: 18487356
Am J Respir Cell Mol Biol. 2014 Sep;51(3):334-43
pubmed: 24828366
Sci Rep. 2016 Dec 22;6:39668
pubmed: 28004801
BMJ. 2007 Jan 27;334(7586):197
pubmed: 17175568
Front Pharmacol. 2017 Dec 05;8:894
pubmed: 29259556
Trends Microbiol. 2012 Jan;20(1):50-7
pubmed: 22153753
Drugs. 1994 Sep;48(3):386-403
pubmed: 7527760
J Investig Med. 2012 Dec;60(8):1141-6
pubmed: 23072902
Am J Respir Cell Mol Biol. 2007 Mar;36(3):313-23
pubmed: 17008635
Ann Thorac Surg. 2017 Sep;104(3):998-1004
pubmed: 28610885

Auteurs

Vincenzo Giuseppe Genna (VG)

Centre for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, Modena, Italy. vg.genna@gmail.com.
Holostem Terapie Avanzate S.r.l., Modena, Italy. vg.genna@gmail.com.

Davide Adamo (D)

Centre for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, Modena, Italy.

Giulia Galaverni (G)

Centre for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, Modena, Italy.

Fabio Lepore (F)

Centre for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, Modena, Italy.

Federica Boraldi (F)

Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Daniela Quaglino (D)

Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Filippo Lococo (F)

Thoracic Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Università Cattolica del Sacro Cuore, Rome, Italy.

Graziella Pellegrini (G)

Centre for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, Modena, Italy. graziella.pellegrini@unimore.it.
Holostem Terapie Avanzate S.r.l., Modena, Italy. graziella.pellegrini@unimore.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH